Neutra (NTRR) Aktie Kurs

Neutra Corp. generates revenue by marketing and selling nutraceutical products derived from all natural and organic origins, primarily focusing on the medical cannabis market. The company sells hemp-derived products, including those containing delta-8-THC and other cannabinoids, under its own brand. It entrusts manufacturing to a nutraceutical contractor for private labeling, targeting consumers interested in healthy living solutions. Subsidiaries such as Diamond Anvil Designs, LLC, Deity Corporation, and Vivis Corporation support its operations. The firm's primary customers are consumers seeking natural health products, particularly within the growing nutraceutical sector. Products are sold under the Neutra Corp. brand, emphasizing all-natural and organic origins. The company plans to research new technologies for the nutraceutical space, aiming to expand its product offerings in the medical cannabis sub-market. Neutra Corp. operates in the nutraceutical space by leveraging private-label manufacturing, allowing it to focus on research and development of new technologies. Its product line centers around hemp-derived items, including delta-8-THC products, which are sold directly to end consumers. The company's strategy involves expanding its presence in the medical cannabis market through branded, organic, and natural health solutions.